Total Debt Summary of AstraZeneca PLC

AstraZeneca PLC's latest annual total debt in 2023 was 28.62 Billion USD , down -2.09% from previous year.
AstraZeneca PLC's latest quarterly total debt in 2024 Q1 was 34.55 Billion USD , up 20.71% from previous quarter.
AstraZeneca PLC reported annual total debt of 29.23 Billion USD in 2022, down -5.03% from previous year.
AstraZeneca PLC reported annual total debt of 30.78 Billion USD in 2021, up 51.04% from previous year.
AstraZeneca PLC reported quarterly total debt of 34.55 Billion USD for 2024 Q1, up 20.71% from previous quarter.
AstraZeneca PLC reported quarterly total debt of 29.83 Billion USD for 2023 Q2, down -5.29% from previous quarter.

Annual Total Debt Chart of AstraZeneca PLC (2023 - 1990)

Historical Annual Total Debt of AstraZeneca PLC (2023 - 1990)

Year	Total Debt	Total Debt Growth
2023	28.62 Billion USD	-2.09%
2022	29.23 Billion USD	-5.03%
2021	30.78 Billion USD	51.04%
2020	20.38 Billion USD	11.81%
2019	18.22 Billion USD	-4.64%
2018	19.11 Billion USD	7.33%
2017	17.8 Billion USD	5.94%
2016	16.8 Billion USD	11.66%
2015	15.05 Billion USD	38.83%
2014	10.84 Billion USD	4.5%
2013	10.37 Billion USD	0.64%
2012	10.31 Billion USD	10.53%
2011	9.32 Billion USD	-2.78%
2010	9.59 Billion USD	-15.14%
2009	11.3 Billion USD	-4.57%
2008	11.84 Billion USD	-21.83%
2007	15.15 Billion USD	1139.25%
2006	1.22 Billion USD	1.83%
2005	1.2 Billion USD	-5.36%
2004	1.26 Billion USD	178.9%
2003	455 Million USD	-46.12%
2002	844.41 Million USD	-38.31%
2001	1.36 Billion USD	61.92%
2000	845.38 Million USD	-24.41%
1999	1.11 Billion USD	7.29%
1998	1.04 Billion USD	-11.06%
1997	1.17 Billion USD	-5.73%
1996	1.24 Billion USD	-2.0%
1995	1.26 Billion USD	8.48%
1994	1.16 Billion USD	-36.55%
1993	1.84 Billion USD	-46.84%
1992	3.46 Billion USD	1.2%
1991	3.42 Billion USD	-1.49%
1990	3.47 Billion USD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	33.53 Billion USD	-2.95%
2024 Q1	34.55 Billion USD	20.71%
2023 Q2	29.83 Billion USD	-5.29%
2023 Q1	31.5 Billion USD	7.77%
2023 Q3	28.57 Billion USD	-4.23%
2023 Q4	28.62 Billion USD	0.16%
2023 FY	28.62 Billion USD	-2.09%
2022 Q3	29.29 Billion USD	-0.78%
2022 Q4	29.23 Billion USD	-0.23%
2022 Q1	31.09 Billion USD	1.03%
2022 FY	29.23 Billion USD	-5.03%
2022 Q2	29.52 Billion USD	-5.05%
2021 Q2	27.49 Billion USD	36.57%
2021 Q4	30.78 Billion USD	-3.54%
2021 FY	30.78 Billion USD	51.04%
2021 Q3	31.91 Billion USD	16.06%
2021 Q1	20.13 Billion USD	-1.22%
2020 Q1	18.57 Billion USD	1.91%
2020 FY	20.38 Billion USD	11.81%
2020 Q4	20.38 Billion USD	-8.77%
2020 Q3	22.33 Billion USD	13.13%
2020 Q2	19.74 Billion USD	6.3%
2019 Q3	18.15 Billion USD	-7.85%
2019 Q2	19.7 Billion USD	-8.68%
2019 FY	18.22 Billion USD	-4.64%
2019 Q1	21.57 Billion USD	12.9%
2019 Q4	18.22 Billion USD	0.38%
2018 FY	19.11 Billion USD	7.33%
2018 Q2	19.66 Billion USD	-0.94%
2018 Q3	20.91 Billion USD	6.34%
2018 Q1	19.85 Billion USD	11.5%
2018 Q4	19.11 Billion USD	-8.61%
2017 Q1	17.4 Billion USD	3.53%
2017 Q4	17.8 Billion USD	-0.25%
2017 Q2	19.72 Billion USD	13.35%
2017 Q3	17.85 Billion USD	-9.5%
2017 FY	17.8 Billion USD	5.94%
2016 Q1	16.31 Billion USD	8.36%
2016 Q4	16.8 Billion USD	-4.95%
2016 Q2	17.57 Billion USD	7.77%
2016 FY	16.8 Billion USD	11.66%
2016 Q3	17.68 Billion USD	0.59%
2015 FY	15.05 Billion USD	38.83%
2015 Q1	10.56 Billion USD	-2.53%
2015 Q3	10.94 Billion USD	-0.55%
2015 Q4	15.05 Billion USD	37.51%
2015 Q2	11 Billion USD	4.15%
2014 Q2	10.07 Billion USD	-2.57%
2014 Q3	9.92 Billion USD	-1.47%
2014 Q4	10.84 Billion USD	9.24%
2014 FY	10.84 Billion USD	4.5%
2014 Q1	10.34 Billion USD	-0.35%
2013 Q1	10.2 Billion USD	-0.98%
2013 Q3	10.27 Billion USD	-1.07%
2013 Q4	10.37 Billion USD	0.98%
2013 FY	10.37 Billion USD	0.64%
2013 Q2	10.38 Billion USD	1.73%
2012 Q3	10.91 Billion USD	17.12%
2012 Q4	10.31 Billion USD	-5.53%
2012 Q1	9.38 Billion USD	0.59%
2012 FY	10.31 Billion USD	10.53%
2012 Q2	9.31 Billion USD	-0.69%
2011 Q3	9.44 Billion USD	-1.39%
2011 Q4	9.32 Billion USD	-1.28%
2011 FY	9.32 Billion USD	-2.78%
2011 Q1	9.96 Billion USD	8.07%
2011 Q2	9.58 Billion USD	-3.85%
2010 Q1	10.56 Billion USD	386.87%
2010 FY	9.59 Billion USD	-15.14%
2010 Q4	9.22 Billion USD	-15.44%
2010 Q3	10.9 Billion USD	631.95%
2010 Q2	1.49 Billion USD	-85.9%
2009 FY	11.3 Billion USD	-4.57%
2009 Q4	2.17 Billion USD	-81.14%
2009 Q3	11.5 Billion USD	-2.67%
2009 Q2	11.82 Billion USD	0.45%
2009 Q1	11.76 Billion USD	-0.68%
2008 Q1	15 Billion USD	-1.02%
2008 FY	11.84 Billion USD	-21.83%
2008 Q2	14.87 Billion USD	-0.86%
2008 Q3	13.37 Billion USD	-10.09%
2008 Q4	11.84 Billion USD	-11.4%
2007 Q1	1.14 Billion USD	-6.3%
2007 FY	15.15 Billion USD	1139.25%
2007 Q2	15.39 Billion USD	1243.72%
2007 Q3	14.39 Billion USD	-6.51%
2007 Q4	15.15 Billion USD	5.27%
2006 Q3	1.2 Billion USD	6.28%
2006 FY	1.22 Billion USD	1.83%
2006 Q4	1.22 Billion USD	1.75%
2006 Q1	1.22 Billion USD	1.83%
2006 Q2	1.13 Billion USD	-7.52%
2005 FY	1.2 Billion USD	-5.36%
2005 Q1	1.2 Billion USD	2.47%
2005 Q2	1.31 Billion USD	9.33%
2005 Q3	1.24 Billion USD	-5.26%
2005 Q4	1.2 Billion USD	-3.46%
2004 Q3	1.26 Billion USD	5.5%
2004 Q2	1.19 Billion USD	218.04%
2004 FY	1.26 Billion USD	178.9%
2004 Q1	377 Million USD	-17.14%
2004 Q4	1.17 Billion USD	-7.35%
2003 Q3	- USD	-100.0%
2003 FY	455 Million USD	-46.12%
2003 Q4	455 Million USD	0.0%
2003 Q2	379.05 Million USD	0.0%
2003 Q1	- USD	-100.0%
2002 Q2	817.63 Million USD	0.0%
2002 Q3	- USD	-100.0%
2002 FY	844.41 Million USD	-38.31%
2002 Q4	844 Million USD	0.0%
2002 Q1	- USD	-100.0%
2001 Q4	1.36 Billion USD	0.0%
2001 Q1	- USD	-100.0%
2001 Q2	907.65 Million USD	0.0%
2001 Q3	- USD	-100.0%
2001 FY	1.36 Billion USD	61.92%
2000 FY	845.38 Million USD	-24.41%
2000 Q1	- USD	-100.0%
2000 Q2	1.19 Billion USD	0.0%
2000 Q3	- USD	-100.0%
2000 Q4	845.38 Million USD	0.0%
1999 Q2	1.42 Billion USD	0.0%
1999 Q3	1.12 Billion USD	-21.3%
1999 Q4	1.11 Billion USD	-0.41%
1999 FY	1.11 Billion USD	7.29%
1998 Q2	1.33 Billion USD	0.0%
1998 FY	1.04 Billion USD	-11.06%
1998 Q4	1.04 Billion USD	0.0%
1997 FY	1.17 Billion USD	-5.73%
1997 Q4	1.17 Billion USD	0.0%
1996 FY	1.24 Billion USD	-2.0%
1996 Q4	1.24 Billion USD	0.0%
1995 Q4	1.26 Billion USD	0.0%
1995 Q2	1.35 Billion USD	0.0%
1995 FY	1.26 Billion USD	8.48%
1994 Q4	1.16 Billion USD	0.0%
1994 FY	1.16 Billion USD	-36.55%
1993 Q4	1.84 Billion USD	0.0%
1993 FY	1.84 Billion USD	-46.84%
1992 FY	3.46 Billion USD	1.2%
1991 FY	3.42 Billion USD	-1.49%
1990 FY	3.47 Billion USD	0.0%

Peer Total Debt Comparison of AstraZeneca PLC

Name	Total Debt	Total Debt Difference
Amgen Inc.	64.61 Billion USD	55.702%
Biogen Inc.	7.33 Billion USD	-290.041%
Gilead Sciences, Inc.	24.98 Billion USD	-14.548%
MIRA Pharmaceuticals, Inc.	5061.00 USD	-565540307.034%
Scilex Holding Company	128.46 Million USD	-22180.345%
Scilex Holding Company	128.46 Million USD	-22180.345%

Global Stocks Search

AstraZeneca PLC (AZN)

Total Debt Summary of AstraZeneca PLC

Annual Total Debt Chart of AstraZeneca PLC (2023 - 1990)

Historical Annual Total Debt of AstraZeneca PLC (2023 - 1990)

Peer Total Debt Comparison of AstraZeneca PLC